Locus Biosciences has disclosed receiving a $23.9 million investment from BARDA, intended to back the inaugural Phase 2 study of its groundbreaking CRISPR-crafted phage treatment.

Metronidazole, a small molecule drug approved in 1960 by Pfizer Inc., inhibits DNA synthesis and is highly effective against anaerobic bacteria and protozoa.

Onward Therapeutics has begun recruiting for an initial phase clinical study of their innovative dual-targeted antibody, OT-A201, which engages with two distinct immune control points.

Pantoprazole is a small molecule medicine classed as a proton pump inhibitor, which means it reduces the amount of acid generated in the stomach.

Ivermectin, a small molecule drug, operates as a modulator of the glutamate-gated chloride channel, an action that forms the basis of its pharmacological activity.

PharmAbcine Initiates Dosing in Early-Stage Study for PMC-309 with KEYTRUDA (pembrolizumab) in Subjects Facing Severe Solid Cancers.

Prednisone is a widely-used corticosteroid drug for treating inflammatory conditions such as allergies, arthritis, and asthma, working by suppressing the immune system to reduce inflammation.

Harbour BioMed has been granted FDA approval to initiate human trials for their bispecific antibody, HBM9027, in the U.S.

Amlodipine is a calcium channel blocker medication designed to treat hypertension and angina. It works by relaxing blood vessels and promoting blood flow.

Tramadol is a prescription painkiller used for moderate to severe pain relief. It works by binding to opioid receptors in the brain and spinal cord, reducing pain perception.

Biosion has received approval from the FDA for its investigational new drug application concerning BSI-082, an innovative monoclonal antibody targeting SIRPα.

Sertraline, a widely used SSRI drug for treating depression, anxiety, and OCD in adults and children, affects brain neurotransmitter interactions.